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Abstract
Astrocytes are the most abundant cell type in the central nervous system (CNS) and have a multitude of functions that
include maintenance of CNS homeostasis, trophic support of neurons, detoxification, and immune surveillance. It has only
recently been appreciated that astrocyte dysfunction is a primary cause of many neurological disorders. Despite their
importance in disease very little is known about global gene expression for human astrocytes. We have performed a
microarray expression analysis of human fetal astrocytes to identify genes and signaling pathways that are important for
astrocyte development and maintenance. Our analysis confirmed that the fetal astrocytes express high levels of the core
astrocyte marker GFAP and the transcription factors from the NFI family which have been shown to play important roles in
astrocyte development. A group of novel markers were identified that distinguish fetal astrocytes from pluripotent stem
cell-derived neural stem cells (NSCs) and NSC-derived neurons. As in murine astrocytes, the Notch signaling pathway
appears to be particularly important for cell fate decisions between the astrocyte and neuronal lineages in human
astrocytes. These findings unveil the repertoire of genes expressed in human astrocytes and serve as a basis for further
studies to better understand astrocyte biology, especially as it relates to disease.
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Introduction
Astrocytes are process-bearing glial cells that comprise at least
20–25% and possibly up to 50% of the total volume in some
regions of the central nervous system (CNS). They play an
integral role in normal homeostasis of the adult brain providing
trophic support to neurons and oligodendrocytes as well as
degrading potential toxins. Amongst many other functions,
astrocytes have important roles in glutamate biology, axonal
guidance, the inflammatory response and wound healing,
formation of the blood brain barrier, iron metabolism, and
myelination [1]. Because astrocytes have such diverse functions
it is not surprising that they have been implicated in many
human diseases including amyotrophic lateral sclerosis, epilepsy,
and Parkinson’s disease [2].
A great deal of progress has been made in understanding
astrocyte development in recent years. Like all other neural cells
in the CNS, astrocytes develop from multipotent neuroepithelial
cells or neural stem cells (NSCs). Neuronal formation precedes
gliogenesis in the course of normal development. Studies of
astrocyte development have revealed that the bone morphoge-
netic protein (BMP), fibroblast growth factor-2 (FGF2), signal
transducer and activators of transcription (STAT), heregulin,
and NOTCH signaling pathways are critical for proper
formation of this cell type with considerable cross-talk between
these pathways [3–7]. BMPs activate basic helix-loop-helix
(bHLH) factors from the ID and HES families to repress
proneural bHLH factors and initiate gliogenesis [8]. It is
believed that this differentiation program is locked into place by
induction of the neuronal restrictive silencing factor (NRSF)
which inhibits neurogenesis and promotes gliogenesis [9].
Studies also suggest that the transcription factor NFIA is critical
for the initiation of gliogenesis by inducing expression of the
Notch effector HES5 [10]. NFIA expression in turn is regulated
by SOX9 which complexes with NFIA to turn on a gliogenesis
transcriptional program [11]. When overexpressed in glioma
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cells, NFIX, a paralog of NFIA, has also been shown to
regulate astrocyte maturation by activating expression of several
genes found in mature astrocytes [12]. Mouse knock-out studies
have not been completely conclusive about the role of NFI and
SOX genes in gliogenesis because of redundancy in these gene
families but they do suggest that SOX9 and NFIA have a role
in glial, particularly astroglial, development [13–14]. Another
pathway that has been shown to have a critical role is
gliogenesis is the MAPK pathway which can regulate differen-
tiation of astrocytes and oligodendrocytes through MEK
activation [15]. It is likely that there is additional crosstalk
between the transcription factors and signaling pathways
described above that has yet to be elucidated.
Cell culture models in which NSCs are differentiated to
astrocytes and subsequent global gene expression analysis of a
homogeneous population of cells can help identify new genes
that are pivotal for astrogenesis. These types of analyses can
also offer insights into the transcriptome of mature astrocytes
and will be particularly useful for studying human astrocytes.
Previously microarray data has only been available for murine
astrocytes and human glial precursors [16–17]. We have
recently published a paper describing a new method for the
differentiation of astrocytes from human pluripotent stem cells
(PSCs) using heregulin-b1 and performed a time-course
microarray analysis from days 14–35 of astrocyte differentiation
[18]. In this current study we have expanded the array datasets
to include comparisons of human fetal astrocytes from two
commercial suppliers comparing our results with those of the
previous studies to identify genes and signaling pathways that
are critical for astrocyte maturation and function. The
availability of this data will make it possible to test and verify
predictions about the importance of specific pathways and genes
in astrocyte development and biology. Additionally, the data
offers a new series of potential unique astrocyte markers that
can be used to ascertain the purity of astrocyte populations that
are differentiated from NSCs. Such information will be
particularly useful for the large scale production of homoge-
neous astrocyte cultures for high throughput drug screens and
for understanding neurological disorders resulting from astrocyte
dysfunction.
Materials and Methods
Cell culture
Astrocytes from human fetal cortex were purchased from
Lonza (Walkersville, MD USA) and ScienCell (Carlsbad, CA
USA) and grown according to manufacturer’s instructions. The
Lonza astrocytes were grown on uncoated tissue culture plates
Figure 1. Characterization of NSC and fetal astrocyte samples. (A) NCRM-5 iPSC derived NSCs and H9 ESC derived NSCs were examined for
Nestin expression (green) which was overplayed with Hoechst nuclear stain (blue) to show all cells, (B) Lonza fet ast (fetal astrocytes) and Sciencell fet
ast (fetal astrocytes) were examined for GFAP expression (green) which was overplayed with Hoechst nuclear stain (blue) to show all cells, (C)
dendrogram showing relationship between NSCs and fetal astrocytes at the global gene expression level and a table showing correlation coefficients
amongst all samples.
doi:10.1371/journal.pone.0096139.g001
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in Lonza’s Astrocyte basal medium with L-glutamine, gentami-
cin, 3% FBS and supplemented with Lonza’s astrocyte growth
medium SingleQuots (ascorbic acid, EGF, insulin). The cells
were passaged with trypsin/EDTA once they reached 80%
confluence. ScienCell astrocytes were grown on poly-L-lysine
coated plates in the company’s astrocyte medium and passaged
with trypsin/EDTA once the plates were 80% confluent.
NSCs used in this study were either derived from human
PSCs using an embryoid body (EB) intermediate as previously
described [19], derived by direct induction [20], or purchased
from Life Technologies and cultured in StemPro NSC SFM
medium ((Life Technologies, Grand Island, NY, USA). The
direct induction protocol utilizes a Neural Induction medium
(Life Technologies) in which PSCs are initially seeded at a low
density and grown for one week to become neuroepithelial cells,
then switched over to a neural expansion medium (Life
Technologies) for generation of NSCs that can be passaged
and cryopreserved. Once the NSC lines were established they
Table 1. DAVID GO term analysis of genes enriched 5-fold in Lonza and ScienCell fetal astrocytes.
TERM p-value # GENES
Antigen processing 2.70E-08 8
Extracellular matrix 9.90E-07 22
Blood vessel development 1.50E-06 19
Cell adhesion 2.20E-05 17
Wound healing 8.50E-05 14
Secreted 1.30E-04 49
Inflammation 6.50E-04 8
Cell motion 1.10E-03 21
Apoptosis regulation 2.10E-03 29
MAPK activity 3.90E-03 8
doi:10.1371/journal.pone.0096139.t001
Table 2. Gene highly enriched in both fetal astrocyte samples and expressed at very low levels in NSCs or differentiated neurons.
SYMBOL LONZA FET AST SCIENCELL FET AST NCRM-5 NSC H9 NSC
BEND6 216 308 3 10
CD44 3920 4352 145 233
CDKN2B 1141 440 13 17
COBL 100 399 17 7
CRYAB 1305 1230 7 1
DUSP23 1004 432 11 11
GFAP 3280 1456 8 1
HEY1 727 805 114 29
HOPX 1309 1417 210 1
IGFBP7 1487 1623 31 18
ITGA3 1056 1039 88 88
LGALS3 3055 1599 52 2
LHX2 4177 4542 2 16
LMO2 360 1674 6 1
LPPR4 431 537 1 1
MVP 266 323 16 6
NFIX 4122 1730 4 1
PRRX1 286 828 1 4
S100A6 3500 2917 40 28
SLC25A18 623 303 4 5
SYNC1 1084 395 32 8
TDRD7 264 292 5 8
TGFB3 959 156 15 10
TM4SF1 643 589 20 105
doi:10.1371/journal.pone.0096139.t002
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were grown in StemPro NSC SFM consisting of KO-DMEM/
F12, StemPro Neural Supplements, 20 ng/ml FGF2, and
20 ng/ml EGF (all from Life Technologies). The differentiated
neurons used in this study were derived from iPSC-derived
NSCs with neuronal differentiation medium as previously
described [21] and iPSC-derived astrocytes used in this study
were generated with a slight modification of previously
described astrocyte differentiation medium [18] consisting of
DMEM/F12, GlutaMAX-I, B27 supplement, 8 ng/ml FGF2,
and 10 ng/ml of heregulin-b1 (all components from Life
Technologies except heregulin which was from Peprotech
(Rocky Hill, NJ USA).
Immunofluorescence
Cells were processed for staining by fixation in 4% paraformal-
dehyde for 10 minutes at room temperature followed by three
washes in PBS. They were then incubated in blocking buffer
containing 10% goat serum, 0.1% Triton-X, and 1% bovine
serum albumin for 30 minutes followed by overnight incubation at
4uC with primary antibodies in blocking buffer. Primary
antibodies used in this are described in Table S1. After removal
of primary antibody the cells were washed with PBS three times
and incubated with Alexa fluor secondary antibodies and Hoechst
in blocking buffer (1:500 for Alexa and 1:2000 for Hoechst, both
from Life Technologies) for two hours at room temperature.
Staining was visualized on a fluorescence microscope with the
appropriate filter settings.
Figure 2. HOPX, LHX2, and PRRX1 staining of fetal astrocytes. Lonza and Sciencell fet ast (fetal astrocytes) were stained with HOPX (A), LHX2
(B), and PRRX1 (C) antibodies. The antibody signal is in green and is overplayed with HOECHST (blue) to show all cells.
doi:10.1371/journal.pone.0096139.g002
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Bead array hybridization
The Lonza astrocytes were grown in a T75 to 80% confluence
and cells collected for microarray hybridization after the first
passage. Astrocytes from ScienCell were grown in a 6 cm cell
culture dish, passaged once into a T75, grown to 80% confluence
and collected for microarray hybridization. Pelleted cells were sent
to Qiagen (Frederick, MD USA) for extraction, amplification,
labeling and hybridization of RNA to an Illumina HT-12 v4
BeadChip array. The.idat files for the arrays were sent to us for
analysis.
Bead array analysis
The Gene Expression module of the Illumina GenomeStudio
software package was used to process the.idat files. The data
were normalized with background subtraction and scatter plots
and dendrograms were generated. The data were exported to
Excel for further ‘‘cleaning’’ by removing any probes in which
the intensity value was ,50 for all samples and all intensity
values less than 1 were converted to 1. Expression fold changes
for each commercial astrocyte sample compared to an NSC
sample were calculated and only those genes which showed
greater than 5-fold changes in expression were considered as
cell-type specific markers. Gene lists from relevant developmen-
tal pathways, all human transcription factors, and growth factors
and their receptors were interrogated against this dataset. This
dataset was also analyzed for expression of genes found to be
enriched in other astrocyte gene expression studies and from an
array dataset generated from neurons differentiated from iPSC-
derived NSCs [16,18,21].
Transcription factor binding site analysis
We employed PWMSCAN to predict binding sites of TFs
[22] This method performs computational identification of the
binding sites by scanning promoter sequences using PWMs
(Position Weight Matrices) of TF binding motifs. The predicted
binding site is then evaluated by the P value, which is calculated
through a permutation-based method, FastPval [23]. A sequence
hit with P-value less than the user specified cutoff is considered
as a putative binding site. Moreover, the putative binding sites
can be further filtered based on conservation scores between
human and mouse genomes, which are evaluated by another
permutation-based test. In this study, we scanned three
promoter regions: 1) 2500 bp (upstream to TSS) , +100 bp
(downstream to TSS); 2) 22000 bp , 2500 bp; 3) 28000 bp
, +2000 bp, which were downloaded from the UCSC genome
browser. We retrieved PWMs of TFs available from two
databases TRANSFAC and Jaspar.
Inhibition of NOTCH signaling with DAPT
For Notch pathway inhibition ,100,000 NSCs were plated
onto poly-L-ornithine/laminin-coated 24-well plates. The next
day cells were either grown in NSC medium or the medium was
changed to either neuronal differentiation medium or astrocyte
differentiation medium. The Notch pathway inhibitor DAPT
(Sigma Aldrich, St. Louis, MO USA) was added to the medium at
a concentration of 10 mM. The cells were grown for an additional
four days with medium changes every other day and then
processed for immunofluorescence for the neuronal marker beta-
III-tubulin and the astrocyte marker GFAP. Beta-III-tubulin
positive cells were quantified by calculating the number of positive
cells in three separate fields of view. A t-test was performed to
assess statistical significance between samples.
Lentiviral infection
cDNAs for NFIX and HOPX in second generation lentiviral
vectors were purchased form Thermo Scientific (Pittsburgh, PA
USA). A control GFP lentiviral cDNA was used as well. One
million NSCs plated in three wells of a 6-well plate were infected at
an MOI of 10 and three days later cells were either maintained in
NSC medium or switched to astrocyte or neuronal differentiation
medium. Two days after the medium change the cells were
analyzed qPCR for NSC, astrocyte, and neuronal markers with
beta-actin as a normalization control. Lonza astrocytes were
similarly infected and analyzed by qPCR three days after
infection. Total RNA from GFP-control, HOPX-, and NFIX-
lentivirus infected cells was extracted using RNeasy Mini Kit
(Qiagen, CA). cDNA was generated from 1 mg total RNA using
SuperScript III First -Strand Synthesis System kit (Life Technol-
ogies, CA). The b-actin gene was employed as an endogenous
control to normalize input cDNA. qPCR reactions was performed
on the Applied Biosystems ViiA 7 Real-Time PCR Sytsem
(Applied Biosystems, CA) using Fast SYBR Green Master Mix Kit
(Life Technologies, CA). The comparative CT method was used to
determine the relative target mRNA quantity in samples. The
primers used are described in Table S2.
Results
Characterizing fetal astrocyte and iPSC-derived NSCs
samples used for microarray analysis
In an effort to identify genes involved in regulating astrocyte
development we examined the expression profile of fetal
astrocytes obtained from Lonza and ScienCell and compared
their expression profile to NSC lines derived from both an iPSC
line by direct induction (hereafter referred to as NCRM-5
Table 3. Summary pathways analyzed in microarray.
Pathway # Genes
Expressed 2/2
fet ast Expressed 2/2 NSC Up 2/2 fet ast Down 2/2 fet ast
Transcription factors 1900 802 799 46 51
Notch 95 54 45 9 1
TGF-beta 135 54 48 5 3
JAK/STAT 206 55 49 6 4
MAPK 536 224 220 20 15
Growth factors 377 88 64 18 3
Growth factor receptors 63 15 18 3 3
doi:10.1371/journal.pone.0096139.t003
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NSCs) and NSCs purchased from Life Technologies that were
derived via an embryoid body (EB) based rosette method from
the human H9 embryonic stem cell line (H9 NSCs). Gene
expression data from previous microarray experiments indicated
Table 4. Transcription factors upregulated in both sets of fetal astrocytes compared to both NSC samples.
SYMBOL LONZA FET AST SCIENCELL FET AST NCRM-5 NSC H9 NSC
BCL6 280 406 54 24
BHLHB2 1233 1069 114 1
BHLHB3 145 187 2 1
CSDC2 425 189 33 21
CXXC5 3189 1658 625 715
DPF3 267 149 11 1
EGR1 3970 3779 1197 443
EMX2 763 311 11 4
ETS2 207 114 23 24
FOS 606 3343 198 63
FOXG1 547 1021 1 14
GLIPR1 850 854 4 64
GLIS3 162 157 68 48
GTF2F2 4033 3423 1437 1564
HEY1 727 805 114 29
HOPX 1309 1417 210 1
ID1 708 389 166 8
IRF9 1394 735 260 168
JUN 2010 1435 605 672
KLF5 165 275 14 7
KLF6 874 879 302 406
KLF9 724 616 132 2
LHX2 4177 4542 2 16
MBNL1 370 504 114 159
NFE2L3 705 200 44 93
NFIA 335 343 80 1
NFIB 5565 3405 1012 287
NFIC 242 175 9 7
NFIX 4122 1730 4 1
NR2E1 529 776 13 8
OTX1 183 100 1 10
PRDM16 161 113 8 3
PRRX1 286 828 1 4
RBM20 133 320 62 12
RUNX2 157 169 29 67
ZBTB20 450 943 72 81
ZBTB4 824 818 303 275
ZC3HAV1 312 291 135 121
ZFP3 202 212 19 9
ZFP36 218 333 69 102
ZNF135 368 216 41 38
ZNF385D 387 101 39 2
PHF11 638 512 9 2
PHF15 152 199 18 7
SETD6 196 129 16 23
SMARCA2 897 1052 238 188
doi:10.1371/journal.pone.0096139.t004
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Table 5. Transcription factors upregulated in both sets of NSC samples compared to both fetal astrocytes.
SYMBOL LONZA FET AST SCIENCELL FET AST NCRM-5 NSC H9 NSC
ARID3B 72 33 431 737
CBX2 155 80 695 494
CHD7 277 388 2277 1863
CHX10 1 16 204 108
CXXC4 51 51 827 287
CXXC6 17 26 200 220
E2F2 210 301 1064 834
EBF1 19 1 146 146
ETV4 36 54 217 143
EZH2 204 253 740 533
FLI1 32 13 177 501
GLI2 71 48 189 176
H1FX 268 297 629 606
HES6 551 527 3211 1653
HIC2 153 77 800 1039
IRX2 70 23 410 2254
IRX5 48 29 458 342
KNTC1 372 473 1495 1122
LIN28 1 1 276 1218
LIN28B 1 6 649 1955
MYCN 74 90 1299 785
MYST3 643 621 1624 1489
PBX2 104 144 327 299
PHF16 106 101 350 332
PKNOX2 141 102 751 304
PLAGL2 182 237 536 532
POU3F2 839 944 3439 2596
PRDM8 22 36 2559 108
RAPGEF5 22 17 146 108
RCOR2 57 43 1187 663
SALL2 597 541 2225 1498
SALL4 39 17 458 1024
SORBS2 176 177 1337 2257
SOX3 351 75 3147 1629
STAT5B 75 44 151 172
SUV420H1 140 111 307 285
TCF7L1 13 17 184 104
TRIT1 382 380 879 857
ZBTB34 53 47 174 175
ZBTB39 41 22 116 85
ZBTB46 56 3 263 350
ZFHX3 181 212 479 745
ZFP14 26 5 108 52
ZMYND8 114 114 415 361
ZNF138 33 34 114 96
ZNF219 157 193 987 761
ZNF431 47 30 108 95
ZNF443 30 44 138 105
ZNF462 429 402 1759 1220
ZNF679 450 425 1167 1551
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that NSC lines derived by either the EB/rosette or direct
induction method have very similar gene expression profiles
[20]. Prior to microarray hybridization the NSCs were
examined for expression of the NSC marker Nestin and nearly
all PSC-derived NSCs were Nestin+ (Figure 1A). Fetal
astrocytes expressed GFAP, a characteristic marker of astrocytes,
and showed clear differences in morphology from one another
(Figure 1B) which likely reflects their distinct cell culture
propagation, passage number, and isolation. Nevertheless, these
cells did not show expression of NSC markers such as Sox1,
and there was no neuronal contamination as assessed by b-III
tubulin staining (data not shown).
The NSCs and fetal astrocytes were hybridized to an
Illumina bead-chip array. Overall ,14,000 genes were ex-
pressed above an intensity threshold of 50 in at least one of the
three samples. This threshold was chosen based on our previous
experience which suggested that genes expressed at intensity
levels below 50 were too variable to consider in an analysis.
The dataset has been deposited an is publicly available
(GSE53404). Prior to gene expression analysis, dendrograms
were generated to compare each of the respective fetal astrocyte
samples to NSCs and to each other (Figure 1B). Despite
differences in cell culture propagation both fetal astrocytes
samples had a high degree of similarity to each other at the
global gene expression level (R2 = 0.94) and formed a cluster
distinct from NSCs (Figure 1C). Likewise, the two NSC lines
had high correlation coefficients (0.95) whereas the fetal
astrocyte and NSC samples were more dissimilar (0.86–0.90).
Identification of fetal astrocyte-marker genes
We reasoned that if a gene was highly upregulated (at least 5-
fold) in two astrocyte samples grown under different conditions
compared to both of the NSC samples it would likely be a
reliable candidate as an astrocyte marker. Therefore, we used
this cut-off to identify new markers that are unique to this cell
type. A total of 350 genes were expressed at least 5-fold higher
in both fetal astrocyte samples in pairwise comparisons to the
two NSC samples (Table S3). Astrocytes play important roles in
immune regulation, wound healing, and modulation of the
brain’s vascular system and a DAVID Gene Ontology search
[24] indicates that genes in these categories are amongst those
most overrepresented of the genes that are at least 5-fold
upregulated in fetal astrocytes (Table 1). The DAVID search
also revealed that the MAPK pathway may play a critical role
in fetal astrocytes which is in line with recent evidence that this
pathway is important for gliogenesis to proceed [15].
In a further attempt to find genes that are most likely to be
astrocyte-specific we tried to eliminate the effects of variables
inherent in using primary samples by comparing the list against
other datasets that we have generated. These datasets were from
additional NSC lines [20], three astrocyte line differentiated
from iPSC-derived NSCs (one from this study and two
Table 5. Cont.
SYMBOL LONZA FET AST SCIENCELL FET AST NCRM-5 NSC H9 NSC
ZNF696 115 83 256 266
doi:10.1371/journal.pone.0096139.t005
Figure 3. Heatmaps for differentially expressed genes from (A) NOTCH, (B) TGF-beta, and (C) JAK-STAT pathways. Heatmaps are
shown for genes differentially expressed between Lonza fetal astrocytes (LON FET AST), Sciencell fetal astrocytes (SC FET AST), H9 NSCs, and NCRM-5
NSCs. All genes show at least 2-fold difference between at least one fetal astrocyte and NSC sample.
doi:10.1371/journal.pone.0096139.g003
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described in ref. 18) as well as cortical neurons differentiated
from iPSC-derived NSCs (described ref 21). The array
expression data for NSCs, NSC-derived neurons and astrocytes
generated in this study has been publicly deposited (GSE55379).
The 350 genes that were 5-fold overexpressed in fetal astrocytes
were cross-checked for being expressed in the three NSC-
derived astrocyte lines and either being absent from or
expressed at low abundance in the other two NSC lines and
in differentiated neurons. A total of 24 genes met these stringent
criteria (Table 2). The list of genes includes the classical
astrocyte marker GFAP and the transcription factor NFIX
which is a paralog of NFIA which is known to be critical for
gliogenesis [10]. Other genes of interest in this group include
the transcriptional regulators LMO2, LHX2, HOPX, and
PRRX1 as well as genes such as BEND6, CDKN2B, IGFBP7,
LGALS3, and MVP that have known or predicted roles in
signaling pathways, including NOTCH and TGF-beta, that are
known to be important in astrocyte function [25–29].
We selected three transcription factors from this list to validate
expression at the protein level in fetal astrocytes. LHX2, HOPX,
and PRRX1 were found to be present in both fetal astrocyte lines
(Figure 2A–C) and absent in NSCs by immunofluorescence (data
not shown). This suggests that the genes are excellent novel marker
candidates for astrocyte.
Analysis of pathways critical for astrocyte development
and maintenance
Transcription factors and signaling pathways such as NOTCH,
TGF-beta, MAP kinase, and growth factor mediated pathways
have been shown to play important roles in astrocyte biology. We
examined each of these pathways in greater depth in our fetal
astrocyte array data. Table 3 summarizes number of genes
expressed and differential expression (2-fold difference) of genes
amongst these pathways in fetal astrocytes and NSCs.
Transcription factors. In order to generate a list of
transcription factors (TFs) expressed in fetal astrocytes we
interrogated our datasets against a list of all human TFs
(Table S4). Table 4 displays the 46 transcription factors that are
upregulated in both fetal astrocyte samples in pairwise compar-
isons to both NSC samples. Transcription factors in this list
include the previously mentioned HOPX, PRRX1, and
NFIX. Other TFs that appear to be enriched in both fetal and
NSC-derived astrocytes include BHLHB2, the NOTCH effector
HEY1 and the NFIX paralogs NFIA and NFIB. The remaining
transcription factors appear to be more specific to fetal astrocytes.
Specifically interesting ones include EMX2, FOXG1, and OTX1
all of which are known to have region specific expression in the
rostral forebrain [30,31]. Curiously the fourth member of the NFI
family NFIC is enriched in fetal astrocytes but not expressed in
NSC-derived astrocyte or the NSC-derived neuronal sample (this
study and [18]).
Table 5 lists the 52 transcription factors downregulated in fetal
astrocytes compared to NSCs. Genes in this list included the
Figure 4. Heatmaps for differentially expressed genes from MAPK pathway. Heatmaps are shown for genes differentially expressed
between Lonza fetal astrocytes (LON FET AST), Sciencell fetal astrocytes (SC FET AST), H9 NSCs, and NCRM-5 NSCs. All genes show at least 2-fold
difference between at least one fetal astrocyte and NSC sample.
doi:10.1371/journal.pone.0096139.g004
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previously identified NSC marker MYCN, SALL4, LIN28, and
LIN28B which are all well-known markers for other stem cell
populations [32–34].
A subset of transcriptional regulators that was examined was
genes involved with chromatin dynamics (Table S5). Six chroma-
tin binding genes were upregulated and nine downregulated in
both sets of fetal astrocytes. Of the genes upregulated in fetal
astrocytes SMARCA2 and SETD6 were similarly regulated in
NSC-derived astrocytes. SMARCA2 but not SETD6 was
upregulated in NSC-derived neurons relative to NSCs. Several
members of this gene group were also downregulated in both fetal
and NSC-derived astrocytes including ARID3A, ARID3B, and
EZH2. Each of these genes was also downregulated in NSC-
derived neurons.
Signaling pathway analysis of microarray data. Four
signaling pathways that are critical for astrocyte development are
NOTCH, TGF-beta, JAK-STAT, and the MAP kinase pathways.
We analyzed each of these pathways in our array dataset
(Table S6–S9). We also examined growth factors and growth
factor receptor expression (Table S10).
NOTCH Pathway. For the NOTCH pathway nine genes
are upregulated in both fetal astrocyte samples and only one
gene is downregulated (Figure 3A). Amongst the upregulated
genes HEY1 and the atypical ligands DLK1 and DNER are
similarly upregulated in NSC-derived astrocytes. HEY1 seems to
be relatively astrocyte specific as it is expressed at low levels in
differentiated neurons while DLK1 and DNER show robust
expression in neurons. The only NOTCH gene downregulated
in fetal astrocytes relative to NSCs is NOTCH3 but it does not
show similar regulation in comparisons between NSCs and
NSC-derived and astrocytes. Despite the fact that there is more
upregulation of selected members of the NOTCH pathway in
fetal astrocytes, most of the components of the canonical
NOTCH pathway are present NSCs, fetal, and NSC-derived
astrocytes and neurons suggesting the pathway is active in all
these cells but perhaps utilized in different manners.
TGF-beta pathway. A total of five genes in the TGF-beta
pathway are upregulated and three downregulated in both fetal
astrocyte samples (Figure 3B). None of the genes upregulated in
fetal astrocytes is similarly regulated in NSC-derived astrocytes
although two of the downregulated genes (BMP7, TGFBR3) are
downregulated in NSC-derived astrocytes. TGFBR3 is a
negative regulator of the TGF-beta pathway so this along with
the other array results suggest this pathway is less active in
NSCs [35]. It should be noted the TGF-beta pathway seems to
be very active in Lonza fetal astrocytes as eight additional genes
in this pathway were upregulated only in this sample. These
cells appear capable of signaling through BMP2/4, GDF10, and
TGFB2/3 whereas Sciencell astrocytes only signal through
TGFB 2/3. NSC-derived astrocytes do not seem to actively
signal via any of these ligands except perhaps TGFB1 which is
expressed at low levels.
JAK/STAT Pathway. Six genes from the JAK/STAT
pathway are upregulated in fetal astrocytes and four are
downregulated (Figure 3C). Cytokines appear to be upregulated
while several growth factor receptors (LIFR, CNTFR) are
downregulated in fetal astrocytes. This appears to be unique to
the fetal astrocytes as none of these are similarly regulated or in
the case of many of the upregulated cytokines even expressed in
NSC-derived astrocytes. It is noteworthy that the LIF and
CNTF receptors are both upregulated in the NSCs with the
latter not even being expressed in fetal astrocytes but only the
Figure 5. Heatmaps for genes differentially expressed growth factor and growth factor receptor genes. Heatmaps are shown for genes
differentially expressed between Lonza fetal astrocytes (LON FET AST), Sciencell fetal astrocytes (SC FET AST), H9 NSCs, and NCRM-5 NSCs. All genes
show at least 2-fold difference between at least one fetal astrocyte and NSC sample.
doi:10.1371/journal.pone.0096139.g005
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LIF ligand is expressed in any of these samples and it is found
only in Lonza fetal astrocytes. Many of the other signaling and
downstream components of the JAK/STAT pathway (JAKs,
STATs, IRFs, TYKs) are found in fetal astrocytes and NSC-
derived astrocytes and neurons suggesting the pathway is active
in these cells as well.
MAPK Pathway. When examining the MAPK pathway a
total of 20 genes are upregulated and 15 downregulated in fetal
astrocytes (Figure 4). Genes that are upregulated include a
receptor tyrosine phosphatase implicated in brain function
(PTPRE), IRS2, and the dual specificity phosphatase DUSP18
[36]. GO analysis and the relatively large number of upregulated
genes in this pathway suggest that MAPK signaling is critical for
maintenance of fetal astrocytes.
Growth factors and growth factor receptors. Eighteen
growth factors and three growth factor receptors are upregulated
in fetal astrocytes whereas only three of each is downregulated in
this cell type relative to NSCs (Figure 5). As described above many
of the upregulated genes are ligands of the TGF-beta family.
Additionally many cytokines are also upregulated in fetal
astrocytes. The PDGRA and MET genes are also upregulated
in fetal astrocytes which is particularly interesting because of the
potential cross-talk between these receptors [37]. It is possible
PDGF signaling is important in fetal astrocytes as the PDGF
ligand PDGFC and PDGFD are also expressed.
Transcription factor binding site analysis of transcription
factors overexpressed in astrocytes
There were several structural genes that were highly enriched in
our dataset. We examined sequences up to 8 kb upstream of the
translation start site for five of these genes (GFAP, CD44,
LGALS3, DUSP23, and S100A6) to determine what transcription
factors bound all of these genes and were also expressed in both
fetal astrocyte samples (Table 6). The 24 genes meeting these
criteria included E2F2 and TCF7L2 which were identified as
being important for gliogenesis in mice [38], and NFIC, SMAD3,
and two STAT genes all of which are known to have critical roles
in astrocyte development. Additionally, conditional knock-out of
mouse serum response factor (SRF) in NSCs resulted in significant
loss of astrocytes in the mouse brain [39]. The fact that these genes
were identified suggests that some of the other genes in this group
may have an important role in astrocyte development and
maintenance.
Inhibition of NOTCH signaling in NSCs
Due to the previous work indicating that NOTCH signaling
plays a central role in astrogenesis and our own findings that
there is upregulation of certain pathway components in
astrocytes relative to NSCs we assessed the effects of inhibiting
this pathway. Multiple genes involved in all stages of the
NOTCH pathway were found in both in fetal astrocytes and
NSCs. In order to better understand the role of Notch signaling
in cell fate choice in NSCs we used DAPT, a small molecule
inhibitor of the Notch pathway. After four days of culture in
Table 6. Transcription factors that are expressed in both fetal astrocyte samples and have binding sites within 8 kb of five highly
astrocyte-enriched structural genes.
SYMBOL LONZA FET AST SCIENCELL FET AST NCRM-5 NSC H9 NSC
ATF1 180 205 151 268
CREB1 1272 1269 1593 1619
E2F2 210 301 1064 834
E2F3 884 1095 1633 1570
EGR1 3970 3779 1197 443
GABPA 130 137 184 121
HBP1 319 177 220 170
LEF1 1122 219 6 222
NFIC 242 175 9 7
NFKB1 1176 684 591 878
RXRA 379 291 464 446
SMAD3 1171 444 687 611
SP1 232 302 387 343
SRF 1655 843 1415 1051
STAT1 703 627 487 353
STAT3 538 369 491 399
TCF3 622 819 1309 1159
TCF7L2 133 182 267 269
TGIF1 221 182 247 258
ZFP161 285 132 371 336
ZNF187 191 161 142 102
ZNF281 457 703 707 924
ZNF410 756 665 775 742
doi:10.1371/journal.pone.0096139.t006
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NSC, astrocyte, or neuronal growth medium iPSC-derived
NSCs exposed to DAPT had increased expression of the
neuronal marker b-III-tubulin (TuJ1) compared to untreated
cells (Figure 6A–C). No GFAP staining was observed in either
the treated or untreated cells and similar results were found in
an ESC-derived NSC line. The percentage of TuJ1+ cells was
quantified and found to be significantly different across all cell
culture medium groups (Figure 6D). The treated cells particu-
larly those in neuronal differentiation medium also displayed
enhanced cell death. We also treated fetal astrocytes with
DAPT but treatment did not result in the appearance of TuJ1+
cells or increased cell death (data not shown).
Overexpression of astrocyte specific transcription factors
in NSCs
Our microarray data and previous studies indicate that NFIX
and HOPX are critical for initiation of transcription programs that
promote astrocyte differentiation and/or maintenance. To better
understand the roles of these genes in astrocyte biology we
transduced lentivirus from NFIX and HOPX, along with a GFP
control, into fetal astrocytes and NSCs and assayed for expression
of selected markers by qPCR. NSCs were further split three days
post-infection and grown in NSC, astrocyte, and neuronal
medium for an additional three days. Fetal astrocytes were readily
infected as evidence by GFP expression while NSC infection
occurred at lower frequency (Figure 7A–B). However, all culture
conditions/cell types had strong overexpression of HOPX and
NFIX (see Table with Figure 7C).
Expression of the early astrocyte marker CD44 increased ,2-
fold with both HOPX and NFIX overexpression in fetal astrocytes
(assayed three days post-infection). Somewhat surprisingly NFIX
overexpression decreased GFAP transcripts ,90% and HOPX
,70% in fetal astrocytes. For NSCs we saw a similar modest
increase in CD44 transcripts in all culture conditions with NFIX
overexpression and a ,2-fold increase with HOPX in neuronal
medium. HOPX also upregulated NFIX expression 2.5–3 fold in
astrocyte and neuronal medium.
As we observed such a large decrease in GFAP and HOPXRNA
expression in fetal astrocytes we performed immunofluorescence to
determine if protein levels also decreased. We were unable to detect
any significant differences in GFAP or HOPX staining between
GFP and NFIX infections (Figure 8A–B). Upon re-examining the
raw qPCR data it appears that the levels of GFAP and HOPX
expression in normal (GFP-treated) astrocytes is so high that even a
large decrease with NFIX infection still leaves highly abundant
Figure 6. DAPT treatment of NSCs promotes neuronal differentiation. NSCs were stained for TuJ1 (green) after being grown for four days
+/2 DAPT in, (A) NSC medium (NSC MED), (B) astrocyte differentiation medium (AST DIFF MED), and (C) neuronal differentiation medium (NEU DIFF
MED) with an overlay of HOECHST staining (blue) to display all cells, (D) table quantifying the percentage of TuJ1 positive cells for each treatment
group. *p-value= 0.03, **p-value= 0.01, ***p-value= 0.0001.
doi:10.1371/journal.pone.0096139.g006
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Figure 7. Lentiviral overexpression of NFIX and HOPX in fetal astrocytes and NSCs. GFP expression in GFP, NFIX-nuclear GFP, and HOPX
nuclear-GFP cells in (A) Lonza fetal astrocytes (LON FET AST), and (B) NSCs. (C) Tables showing qPCR fold-changes of selected genes in fetal astrocytes
and NSCs grown in NSC, astrocyte, or neuronal medium relative to b-actin with GFP lentivirus. The table shows the relative overexpression levels of
the NFIX and HOPX lentiviruses.
doi:10.1371/journal.pone.0096139.g007
Figure 8. GFAP and HOPX expression in NFIX infected fetal astrocytes. Fetal astrocytes were infected with GFP or NFIX and stained with
either (A) GFAP (red), or (B) HOPX (red) antibodies. HOECHST staining (blue) was overplayed to display all cells and GFP (green) to display infected
cells.
doi:10.1371/journal.pone.0096139.g008
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levels of RNA for these genes such that protein levels between GFP
and NFIX infected groups are not affected.
Discussion
We have carried out the first study examining gene
expression in human fetal astrocytes. Previous studies of
astrocyte expression have used murine astrocytes [16], human
glial progenitors [17], or astrocytes derived from PSCs [18].
Our goal was not to do a comprehensive survey of genes
differentially expressed in astrocytes but identify clear astrocyte
specific markers, core pathways and transcription factors
important for astrocyte development and maintenance, and
compare our results to those of previously published datasets.
We reasoned that to achieve this goal for identifying astrocyte
markers, each marker should be at least 5-fold enriched relative
to NSCs, be expressed in the other dataset of PSC-derived
astrocytes, and have very low expression levels in other NSC-
derived neuronal and NSC gene expression datasets [18,20].
Using these criteria, we identified 24 genes that appear to be
enriched in astrocytes compared to NSCs and neurons
differentiated from NSCs. The fact that known astrocyte
markers such as GFAP, CD44, and NFIX are in this list
makes us confident that many of the other genes are also
astrocyte specific. Other astrocyte enriched genes on the list
known to have roles in astrocyte function include LGALS3,
CRYAB, S100A6, TGFB3 [40–43]. We have previously
reported that another gene on this list, HOPX, is enriched in
PSC-derived astrocytes [18] and LHX2 and PRRX1 are
enriched in NSC-derived and mouse astrocytes [15,18]. Several
Notch pathway genes are on this list including HEY1 and a
newly described member of this pathway BEND6. HEY1 has
previously been shown to drive generation of astrocytes at later
stages of mouse brain development [44] and BEND6 was found
to inhibit self-renewal in NSCs from the mouse cortex and
promote neurogenesis through antagonism of the Notch
signaling pathway. Due to the importance of Notch signaling
in astrogenesis BEND6 could be a novel mediator of this
pathway as NSCs differentiate to glia [25].
We also identified nearly 100 transcription factors that are
differentially expressed between astrocytes and NSCs. Some like
HEY1 are known to be effectors of NOTCH signaling and
others like the NFI family of transcription factors are known to
modulate the NOTCH effector HES5 [10]. Additional tran-
scription factors that could play important roles in gliogenesis
include LHX2, PRRX1, and HOPX. Each of these was also
found to be present in mouse astrocytes and astrocytes
differentiated from NSCs [16,18]. Interestingly, fetal astrocytes
and not NSC-derived astrocytes expressed EMX2, FOXG1, and
OTX2 which are not found in NSC-derived astrocytes. These
three genes are well known as forebrain markers and as the
astrocytes used in this study were from the cortex it is possible
that they represent region specific markers for cortical astrocytes
[30,31].
We overexpressed NFIX and HOPX lentivirus in fetal
astrocytes and NSCs finding that both increased CD44 expression
in both cell types while NFIX greatly diminished GFAP and
HOPX expression in fetal astrocytes. However, this decrease of
GFAP and HOPX RNA was not seen at the protein level. It
appears that there is a huge excess of GFAP and HOPX
transcripts produced in fetal astrocytes such that even a large
decrease in the transcription of these genes does not affect the final
levels of protein that is synthesized. Singh et al. [12] have shown
that an NFIX splice variant but not the more common NFIX
mRNA we used can upregulate the GFAP promoter in HEK293
cells and primary astrocytes. Further work will be necessary to
determine exactly how NFIX regulates HOPX and GFAP but as
HOPX did increase NFIX RNA expression in NSCs grown in
several culture conditions it is quite possible that NFIX and
HOPX are part of a regulatory loop that is important for
maintenance of astrocyte identity.
We further studied the role of transcription factors by extracting
binding sites for transcription factors for four of our putative fetal
astrocyte markers. This search yielded several transcription factors
that are expressed in fetal astrocytes including E2F2 and TCFL2
which have been shown to be important for gliogenesis in mice
[38], the NFI member NFIC, and SRF another gene that is critical
for astrocyte generation.
When examining pathways we found that for the NOTCH
pathway two non-canonical ligands, DLK1 and DNER, are
highly overexpressed in astrocytes. DNER activates NOTCH
signaling in Bergmann glia and has been shown to induce glial
and neuronal differentiation in zebrafish while inhibiting NSC
proliferation [45–46]. Conversely, DLK1 has been shown to
inhibit the NOTCH signaling pathway [47–48]. To test the role
of NOTCH signaling in NSCs we treated them with DAPT
and found that in a short period of time it can promote
neurogenesis in several different culture conditions. Inhibition of
NOTCH by DAPT also increased cell death particularly in
neuronal medium. Similar results have been reported when
neural rosettes or NSCs cultured are treated with DAPT [49–
50]. Future studies will need to resolve whether the ability of
NOTCH signaling to both stabilize the NSC state and promote
astrogenesis is due to differential coupling with HES/HEY
genes and involvement of other modulators of Notch signaling
such as BEND6.
The microarray analysis of pathways revealed interesting results
for the TGF-beta pathway. The TGF-beta is highly active in one
subset of fetal astrocytes and relatively inactive in NSCs and NSC
derived astrocytes. Thus, activation of this pathway in NSCs may
enhance astrocyte differentiation. Similarly modulation of JAK/
STAT, MAPK, and PDGF signaling in NSCs is likely to have
significant effects on gliogenesis.
In conclusion, we have elucidated gene expression in fetal
astrocytes and found that they express many previously
described astrocyte marker genes and also express signaling
components from pathways known to be active in this cell type.
We have also identified potentially new human astrocyte
markers that will be of use in distinguishing astrocytes from
other neural cells and transcription factors that could be the
starting point for identifying the core transcriptional circuitry
that defines a human astrocyte. Our results underscore the
importance of a group of transcription factors in astrocyte
development and maintenance and reinforce the importance of
the NOTCH, TGF-beta, JAK/STAT, and MAPK signaling
pathways in this cell type. As such this dataset will be an
important building block for further understanding human
astrocyte biology.
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